Html code here! Replace this with any non empty raw html code and that's it.

Study links GLP-1 drugs to higher risk of hair loss

Date:

Share this article:

Del denne artikel:

A new large-scale study now suggests the treatment may be linked to an increased risk of certain types of hair loss.

Prescriptions for GLP-1 receptor agonists have increased sharply in recent years, driven by their effectiveness in treating type 2 diabetes and promoting weight loss.

The medications are widely known to cause side effects such as nausea and gastrointestinal discomfort.

Data from 500,000

According to researchers writing in the Journal of the American Academy of Dermatology, data from nearly 550,000 adults and adolescents were analyzed to examine whether GLP-1 treatment is linked to alopecia. HealthDay first reported on the findings.

Within a year of initiating therapy, diagnoses of telogen effluvium and androgenetic alopecia appeared more frequently among individuals treated with GLP-1 drugs compared with those who did not use the medication.

Also read: These foods may be ruining your sleep

The association persisted even after adjustments for age, sex, body mass index (BMI), and diabetes status.

Understanding the possible link

The study identifies a statistical association rather than a direct cause-and-effect relationship.

As an observational database study, it cannot determine whether the medication itself triggers hair loss or whether other factors are involved.

Researchers point to rapid weight loss as one plausible explanation.

Also read: Common reasons pain symptoms worsen at bedtime

Telogen effluvium, a temporary form of hair shedding often triggered by physiological or psychological stress, is relatively common in the general population and has previously been linked to significant weight changes.

Hormonal shifts and alterations in insulin levels may also contribute. The possibility that GLP-1 receptor agonists could directly influence hair follicles was also noted but remains unproven.

The authors emphasize that the absolute risk for individual patients was not fully clarified and that further studies are needed, particularly to assess long-term effects and outcomes among teenagers, for whom the available data were limited.

Sources: HealthDay, and Journal of the American Academy of Dermatology.

Also read: The right amount of coffee for better health

Also read: Viagra and shingles vaccine show promise in Alzheimer’s research

Other articles

Craving candy? Try dried jackfruit instead

Many people reach for candy when they crave something sweet, but dried jackfruit could be a good alternative.

These breakfast cereals may help reduce the risk of stroke

A fiber-rich breakfast that includes whole grains, is low in added sugar, and contains limited amounts of salt...

New blood test could make unpleasant cancer examination unnecessary

A new blood test could make it easier to identify women with uterine cancer while sparing many from undergoing an uncomfortable examination.

How to effectively disinfect your home after illness

A thorough and properly carried out cleaning routine can help reduce the risk of infection, experts say.

Craving candy? Try dried jackfruit instead

Many people reach for candy when they crave something sweet, but dried jackfruit could be a good alternative.

These breakfast cereals may help reduce the risk of stroke

A fiber-rich breakfast that includes whole grains, is low in added sugar, and contains limited amounts of salt...

New blood test could make unpleasant cancer examination unnecessary

A new blood test could make it easier to identify women with uterine cancer while sparing many from undergoing an uncomfortable examination.